XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating activities:        
Net loss for the period $ (22,297) $ (22,772) $ (67,385) $ (72,823)
Items not involving cash:        
Depreciation of property and equipment 9,526 9,275 29,686 26,770
Impairment of property and equipment 852 2,663 905 4,679
Amortization of debt discount and issuance costs 1,159 1,140 3,301 2,271
Amortization of intangible assets 1,209 2,620 4,089 8,101
Net amortization contract costs 16 (255) 136 (612)
Deferred income taxes (recovery) (129) (3,258) 350 (9,381)
Net Right of use operating assets/Operating lease liability (80) (220) (479) (317)
Disposal of domain names 1 3 3 3
Accretion of redeemable preferred units 1,863 2,872 9,758 9,247
Loss on debt extinguishment 0 0 0 14,680
Write off of debt discount and issuance cost 0 277 0 277
Loss on change in the fair value of forward contracts 0 0 0 1,624
Amortization of discontinued cash flow hedge 0 0 0 (1,144)
Stock-based compensation expense 1,808 2,308 5,383 6,606
Undistributed earnings of equity method investee (28) 0 (378) 0
Change in non-cash operating working capital:        
Accounts receivable (927) (677) 3,314 (5,785)
Contract assets 31 1,293 1,417 4,177
Inventory 732 12 1,974 (504)
Prepaid expenses and deposits 4,693 1,049 1,312 (2,394)
Deferred costs of fulfillment (212) 1,520 (5,161) (1,964)
Income taxes recoverable 1,376 1,445 753 589
Accounts payable (2,624) (334) (4,151) (5,433)
Accrued liabilities (749) (4,000) (5,593) 293
Customer deposits (1,250) (708) (2,148) 2,957
Deferred revenue 455 (1,216) 7,946 4,623
Accreditation fees payable 11 27 18 (314)
Net cash provided by (used in) operating activities (4,564) (6,936) (14,950) (13,774)
Financing activities:        
Proceeds from issuance of notes payable 62,991 0 62,991 227,258
Redeemable preferred units redemption 0 0 0 (45,718)
Proceeds from redeemable preferred units 0 0 0 35,000
Deferred notes payable financing costs (2,011) 70 (2,011) (6,675)
Deferred preferred financing costs 0 0 0 145
Contingent payments for acquisitions 0 0 0 (1,600)
Proceeds received on syndicated revolver 0 52,382 0 52,382
Repayment of syndicated revolver (2,500) (58,852) (14,500) (68,652)
Payment of syndicated revolver costs (29) (1,238) (48) (1,554)
Net cash provided by (used in) financing activities 58,451 (7,638) 46,432 190,586
Investing activities:        
Additions to property and equipment (14,516) (22,572) (44,793) (77,476)
Acquisition of intangible assets (478) (32) (576) (415)
Net cash provided by (used in) investing activities (14,994) (22,604) (45,369) (77,891)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents 38,893 (37,178) (13,887) 98,921
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of period 52,198 159,595 104,978 23,496
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 91,091 122,417 91,091 122,417
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the interim consolidated balance sheets to the amounts shown in the interim consolidated statements of cash flows above:        
Cash and cash equivalents 75,209 110,736 75,209 110,736
Restricted cash included in funds held by trustee 4,303 3,138 4,303 3,138
Restricted cash included in secured notes reserve funds 11,579 8,543 11,579 8,543
Total Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 91,091 122,417 91,091 122,417
Supplemental cash flow information:        
Interest paid 11,352 5,483 28,856 15,810
Income taxes paid, net 2,451 1,367 5,278 3,342
Supplementary disclosure of non-cash investing and financing activities:        
Property and equipment acquired during the period not yet paid for $ 5,907 $ 74 $ 5,907 $ 74